300966 共同藥業
按盤價 
22.230 +0.380 (+1.739%)
22.230 +0.380 (+1.739%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.217 | -2.942 | 2.446 | 4.634 | 11.677 |
| 總資產報酬率 ROA (%) | -0.390 | -1.054 | 1.019 | 2.451 | 7.772 |
| 投入資產回報率 ROIC (%) | -0.517 | -1.360 | 1.239 | 2.889 | 8.997 | 邊際利潤分析 |
| 銷售毛利率 (%) | 21.771 | 19.673 | 22.091 | 22.862 | 26.386 |
| 營業利潤率 (%) | -7.216 | -7.906 | 3.448 | 6.435 | 10.613 |
| 息稅前利潤/營業總收入 (%) | 0.130 | -4.284 | 5.206 | 8.051 | 15.467 |
| 淨利潤/營業總收入 (%) | -4.846 | -5.899 | 3.759 | 6.536 | 13.212 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 109.138 | 81.610 | 126.537 | 99.920 | 72.662 |
| 價值變動淨收益/利潤總額(%) | 0.947 | 0.767 | 1.289 | -0.474 | -1.219 |
| 營業外收支淨額/利潤總額(%) | 5.778 | 6.837 | -2.164 | -1.012 | 27.178 | 償債能力分析 |
| 流動比率 (X) | 1.040 | 0.953 | 1.267 | 2.107 | 2.576 |
| 速動比率 (X) | 0.504 | 0.477 | 0.690 | 1.356 | 1.462 |
| 資產負債率 (%) | 66.022 | 63.631 | 58.175 | 52.585 | 31.606 |
| 帶息債務/全部投入資本 (%) | 52.214 | 48.608 | 47.019 | 42.809 | 16.758 |
| 股東權益/帶息債務 (%) | 78.510 | 90.535 | 103.431 | 123.588 | 467.952 |
| 股東權益/負債合計 (%) | 46.924 | 52.001 | 66.908 | 85.291 | 210.813 |
| 利息保障倍數 (X) | 0.017 | -1.019 | 2.844 | 4.790 | 17.330 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 127.400 | 133.799 | 121.732 | 106.324 | 119.245 |
| 存貨周轉天數 (天) | 313.812 | 326.128 | 338.014 | 310.224 | 236.696 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 28/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
